Clinical Trial Update: Dual-Tracer Theranostic PET [NA]

View source ↗

Summary

Clinical trial update on dual-tracer theranostic PET imaging for neuroendocrine tumors and prostate cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor
• Prostate Cancer

Snippet

Sponsor: University of Utah | Conditions: Neuroendocrine Tumors, Prostate Cancer | NA | Status: COMPLETED | Results posted: 2025-02-06